Generation Bio Co. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Revenues:
Collaboration revenue
Operating expenses:
Research and development
General and administrative
Loss on lease termination
Total operating expenses

Loss from operations
Other income:
Other income and interest income, net
Net loss and net loss attributable to common stockholders
Net loss per share attributable to common stockholders, basic and diluted
Weighted average common shares outstanding, basic and diluted
Net loss
Other comprehensive (loss) income:
Unrealized gains (losses) on marketable securities
Comprehensive loss
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)
Weighted average common shares outstanding, basic (in shares)
Weighted average common shares outstanding, diluted (in shares)

Comments